MedTrace Logo

Unrelated Donor Stem Cell Transplantation

NCT01364363 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2022-11-23

No results posted yet for this study

Summary

The purpose of this study is to provide an opportunity for patients with malignancies or bone marrow failure states who lack a suitable sibling donor to undergo allogeneic hematopoietic progenitor cell transplantation using cells from unrelated individuals or cord blood registries.

Conditions

Interventions

PROCEDURE

Allogeneic transplantation

Allogeneic transplantation with matched unrelated donors

Sponsors & Collaborators

  • Scripps Health

    lead OTHER

Principal Investigators

  • Jeffrey W. Andrey, MD · Scripps Clinic Medical Group

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-03-31
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01364363 on ClinicalTrials.gov